The betapharm Acquisition: DRL's Inorganic Growth Strategy in Europe

            
 
Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

Case Details:

Case Code : BSTR249
Case Length : 19 Pages
Period : 2002 - 2006
Pub Date : 2007
Teaching Note : Available
Organization : Dr. Reddy's Laboratories Ltd.
Industry : Pharmaceutical
Countries : Germany, Europe, India

To download The betapharm Acquisition: DRL's Inorganic Growth Strategy in Europe and Growth Korea case study (Case Code: BSTR249) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Price:

For delivery in electronic format: Rs. 500;
For delivery through courier (within India): Rs. 500 + Shipping & Handling Charges extra

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

<< Previous

Excerpts

DRL's Acquisition of betapharm

A Gateway to the Second-Largest Generic Market

When 3i put betapharm up for sale in 2005, it attracted the interest of several major pharmaceutical companies around the world, including the world's biggest generic drugs manufacturer, Teva Pharmaceutical Industries Limited. Several reasons were attributed for this interest. The most important factors were betapharm's strong marketing infrastructure and instant access to the German generic market, which many experts believed was very difficult to develop through organic growth. The good value offered by betapharm played a major part in attracting potential buyers. Schuler said on the attractiveness of betapharm to potential buyers, "We have substantially built value by complementing many of business functions such as procurement, finance, and controlling and business development.

All that has led to an independent company with a unique positioning representing a clear gateway to German market, which is the second-largest generics market in the world. This has really sparked a lot of trade interest from the players all around the world, particularly from India..."

Benefits of the Acquisition

The main benefit to DRL from the acquisition was getting an immediate presence in the German generic market and the scope of leveraging this presence to expand in the European market.

Analysts said that DRL acquired this presence without any major liabilities as betapharm was considered a profitable company that was consistently growing at a healthy rate and had a well-planned future products introduction program. Satish Reddy, MD and COO of DRL, explained, "We looked at its turnover and profitability. betapharm has 3.5 per cent market share in Germany; as many as 370 employees, of which there is a strong sales field force of 200; and 145 brands, with a clear launch calendar until 2009. If we had to do all this from scratch, the cost would be prohibitively high... The acquisition was a market entry strategy for us." Niedermaier said that the betapharm acquisition was in line with DRL's ambitious global plans.

He said, "Our business was ideally designed for the German market with its peculiarities, whether it is the healthcare system, product distribution, or communication design. This is our strength. The charm of this combination is that Dr. Reddy's did not have a presence in Germany... Despite its population shrinking, the German healthcare market remains an important one...

Excerpts Contd...>>


Custom Search





Economics for Managers Textbook
Textbooks Collection

Economics for Managers Workbook
ICMR books Collection

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection


 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.